Related Experiment Video
Updated: Feb 7, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Early detection and risk stratification in autoimmune-related interstitial lung disease: a state-of-the-art review
Paolo Delvino1,2, Carlo Alberto Scirè3,4, Valentina Bondi3
1School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy. paolo.delvino@unimib.it.
Abstract:
Interstitial lung disease (ILD) is a major pulmonary complication of autoimmune rheumatic diseases (ARD) and a leading contributor to long-term morbidity and mortality. Although ARDs share underlying immune dysregulation, the onset, radiologic phenotype, and clinical course of ILD vary substantially across individual diseases. Consequently, early detection and structured risk stratification at baseline and during follow-up have become essential elements of care for patients at risk of ARD-related ILD.This review examines the principles and emerging strategies for early identification of ARD-related ILD, emphasizing the role of systematic clinical assessment, high-resolution computed tomography, and longitudinal pulmonary function evaluation in detecting early lung involvement. We discuss how radiologic patterns, functional measures, and serological profiles contribute to prognostic classification in different autoimmune contexts, with particular focus on the early identification of patients at risk of rapid ILD progression. Disease-specific ILD patterns are reviewed across major autoimmune conditions—including systemic sclerosis, idiopathic inflammatory myopathies, primary Sjögren’s syndrome, mixed connective tissue disease, systemic lupus erythematosus, rheumatoid arthritis, and anti-neutrophil cytoplasmic antibody-associated vasculitis—each characterized by distinct risk factors, distinct imaging findings, and divergent prognostic trajectories. Finally, we highlight emerging approaches to risk stratification, including integrated models that combine clinical, radiologic, and serological domains to mitigate the risk of disease progression and guide monitoring strategies.Overall, current evidence supports a precision-medicine framework for ARD-related ILD, in which early recognition and individualized assessment of progression risk are crucial to improving outcomes and informing therapeutic decision-making.
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Lung Capacity
Relative Risk
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

